InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: Grip it and Sip It post# 9196

Thursday, 01/12/2017 2:20:47 PM

Thursday, January 12, 2017 2:20:47 PM

Post# of 233152
Thanks for your transparency Sip it. I'm always open to logical speculation. There are so many ways to connect the dots. I have participated in three private raises - the guys that brought in Nader and financed the transition from Progenics showed me the story four years ago. They are whales compared to my 450k shares. I know Nader has not been happy having to raise at .75 and said that would be the last raise under $2. With the burn rate at $2M per month, CROI or a major catalyst needs to kick in soon… or your speculated handshake deal needs to happen- otherwise they will need to do another raise at a sub $2 offering.

So maybe you are right, they may not even plan on raising anymore $'s because of what you say. They also are able to raise $'s almost overnight with consistency and they do it in small increments. To me that translates to a major tipping point that could come any day. Also WallStreetSTTA is talking up his absolute birdies and proclaiming a major move in the near term. At first I gave him zero credibility but I have to say he has a ton of experience and followers and been spot on consistently. If the data from the P3 Adjunct is clean and I mean every patient continuing on the extension study it would seem a buyout would happen at this juncture and perhaps sooner. Can't imagine GILD waiting through the P3 Mono because the price tag will be crazy big if it were to receive FDA approval.

Pro-140 is gaining traction with the high probability of BTD and Adjunct Approval- thus positioning Pro-140 for the major prize – Mono Therapy. Keep your speculation coming. IMO we shall all soon know our fate as the conclusion to this compelling story is upon us in 2017.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News